This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Optimal Extent of Pulmonary Resection in Clinical ...
Clinical trial

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer (OREX-IA)

Read time: 3 mins
Last updated:15th Feb 2017
Identifier: NCT03066297

The investigatros hypothesized that selection of surgical procedure according to the pre-defined institutional decision-making algorithm will not compromise the treatment outcomes including overall survival and disease-free survival in participants with clinical stage IA non-small cell lung cancer.

The purpose of this study is to determine the outcome of participants with clinical stage IA NSCLC treated by 3 types of surgical resection (wide wedge resection, segmentectomy, or lobectomy) according to the institutional decision-making algorithm

The investigators are planning to enroll 1,000 participants who meet the pre-defined eligibility criteria over 5 years.


Study Type: Observational [Patient Registry]
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: A Prospective Study to Optimize the Extent of Pulmonary Resection According to the Decision-Making Algorithm in Patients With Clinical Stage IA Non-Small Cell Lung Cancer
Estimated Enrollment: 1000
Actual Study Start Date: February 15, 2017
Estimated Study Completion Date: February 15, 2027
Estimated Primary Completion Date: February 15, 2027 (Final data collection date for primary outcome measure)

Groups/Cohorts:
- Lobectomy
- Segmentectomy
- Wide wedge resection

Category Value
Date last updated at source 2017-03-01
Study type(s) Observational study
Expected enrolment 1000
Study start date 2017-02-15
Estimated primary completion date 2027-02-15

View full details